Is Nuvation Bio (NUVB) One of the Best American Penny Stocks to Buy?

Core Insights - Nuvation Bio Inc. (NYSE:NUVB) is recognized as one of the best American penny stocks to buy currently, with an increased price target from $6 to $8 by Citizens, maintaining a Market Outperform rating [1][2] Group 1: Company Performance - Nuvation Bio Inc. successfully initiated treatment for 204 patients with IBTROZI (taletrectinib) in Q3 2025, exceeding expectations and outperforming other recent ROS1 inhibitor launches [2][3] - The updated data for IBTROZI (taletrectinib) indicates unprecedented durability, leading Citizens to raise its short-term forecasts for Nuvation Bio Inc. [3] Group 2: Market Position - Nuvation Bio Inc. is a biopharmaceutical company focused on developing oncology therapeutics, particularly for ROS1-positive non-small cell lung cancer [3][4]